{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-019353","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2025-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.834592+00:00","generated_at":"2026-05-17T02:21:58.962966+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Calidi Biotherapeutics forms Scientific Advisory Board to advance RedTail platform and CLD-401","bullets":["SAB members include Drs. Mace Rothenberg (ex-Pfizer CMO), Dmitriy Zamarin (Mount Sinai), John Wrangle (MUSC), David Curiel (WashU).","RedTail platform uses enveloped vaccinia virus overexpressing CD55 for systemic delivery of genetic medicines to tumor sites.","Lead candidate CLD-401, in IND-enabling studies, targets NSCLC, head & neck, and other cancers with high unmet need.","CLD-401 is designed to home to metastases, replicate only in tumor cells, and express IL-15 superagonist.","SAB will guide efficient development of CLD-401 into the clinic and advance RedTail platform utility."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-019353","json":"https://secwatch.observer/filing/0001493152-25-019353.json","markdown":"https://secwatch.observer/filing/0001493152-25-019353.md","text":"https://secwatch.observer/filing/0001493152-25-019353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315225019353/0001493152-25-019353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315225019353/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:21:58.962966+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}